The Potential Role of Aripiprazole Augmentation for Major Depressive Disorder with Anxious Distress in Naturalistic Treatment Setting-Reference-Cited by-同舟云学术

The Potential Role of Aripiprazole Augmentation for Major Depressive Disorder with Anxious Distress in Naturalistic Treatment Setting

Published:2024-02-04 Issue:2 Volume:22 Page:370-375
ISSN:1738-1088
Container-title:Clinical Psychopharmacology and Neuroscience
language:en
Short-container-title:Clin Psychopharmacol Neurosci

Author:

Lee Seung-Hoon¹^ORCID,Lee Kyung Ho²³^ORCID,Han Tae Sun⁴^ORCID,Han Changsu¹^ORCID,Bahk Won-Myong⁵^ORCID,Lee Soo-Jung⁵^ORCID,Patkar Ashwin A.⁶^ORCID,Masand Prakash S.⁷^ORCID,Pae Chi-Un³⁵^ORCID

Affiliation:

1. Department of Psychiatry, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea

2. Department of Dermatology, Bucheon St. Mary’s Hospital, The Catholic University of Korea College of Medicine, Bucheon, Korea

3. Cell Death Disease Research Center, College of Medicine, The Catholic University of Korea, Seoul, Korea

4. Yonsei St. Mary’s Mental Clinic, Bucheon, Korea

5. Department of Psychiatry, The Catholic University of Korea College of Medicine, Seoul, Korea

6. Avance Psychiatry at Centers of Excellence, Raleigh, NC, USA

7. Duke-NUS Medical School, Singapore

Publisher

Korean College of Neuropsychopharmacology

Link

https://pdf.medrang.co.kr/CPN2/2024/022/cpn022-02-17.pdf

Reference32 articles.

1. The role of anxious distress in immune dysregulation in patients with major depressive disorder

2. Reliability and validity of the DSM-5 Anxious Distress Specifier Interview

3. MAJOR DEPRESSIVE DISORDER IN DSM-5: IMPLICATIONS FOR CLINICAL PRACTICE AND RESEARCH OF CHANGES FROM DSM-IV

4. The Clinical Observation of Inflammation Theory for Depression: The Initiative of the Formosa Long COVID Multicenter Study (FOCuS)

5. Efficacy and Safety of Escitalopram, Desvenlafaxine, and Vortioxetine in the Acute Treatment of Anxious Depression: A Randomized Rater-blinded 6-week Clinical Trial